Andere Sprachen Argent BioPharma Limited Australian S.E.

Aktien

Verzögert Australian S.E. Andere Börsenplätze 03:18:36 07.06.2024			% 5 Tage	% 1. Jan.
0,32 ^AUD	0,00 %		-13,51 %	-32,63 %

15.04.

Argent BioPharma Reports CFO Appointment	07.05.
Argent BioPharma shares begin trading on OTCQB Venture Market	07.05.
Argent BioPharma Begins Trading on US OTCQB Venture Market	07.05.
Argent Biopharma Limited Announces the Appointment of Mr. Igor Bluvstein as Chief Financial Officer	07.05.
CEO Roby Zomer discusses Argent BioPharma's future in pharmaceuticals	01.05.
Argent BioPharma Limited Announces Appointment of Shlomo Sadoun to the Advisory Board	15.04.

Keine Ergebnisse zu dieser Suche